Snowball logo
logo
AMRX_logo

Amneal Pharmaceuticals, Inc

AMRX β€’ NYSE
$17.91+$0.01Β  (0.06%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
2,093.72,212.32,393.62,7943,018.83,117.5
COGS
1,324.71,420.81,529.71,773.51,882.71,891.8
Gross Profit
769791.5863.91,020.41,136.11,225.8
Operating Expenses & Income
Operating Income
152.7(94.93)204.4249.3423.1403.2
Total Operating Expenses
616.3886.4659.5771.1713822.5
R&D Expenses
209.6208.7194.8190.7186.2177.7
Selling General & Admin Expenses
365.7382.9417.3442526.8619.6
Earnings from Continuing Operations
Interest Expense
(136.3)(158.4)(210.6)(258.6)(241.1)(227.5)
Interest Income
------
Income Tax Expense
11.26.6628.45218.8611.28(14.14)
Net Income
Net Income
10.62(130)(83.99)(116.9)72.06157.4
Supplemental
EBIT
167.7200271.4203.6380.3457.9
EBITDA
401.1440.2500.8439.8603.9652.2
In millions of USD, except % and values per 1 share